bioRxivBiochemistry
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
R. Derking, J. D. Allen, C. Cottrell, K. Sliepen, G. E. Seabright, W.-H. Lee, K. Rantalainen, A. Antanasijevic, J. Copps, A. Yasmeen, P. van der Woude, S. W. de Taeye, T. L. G. M. van den Kerkhof, P. J. Klasse, G. Ozorowski, M. J. van Gils, J. P. Moore, A. Ward, M. Crispin, R. W. Sanders
Abstract
SummaryThe HIV-1 envelope glycoprotein (Env) trimer is decorated with N-linked glycans, which are attached to asparagine residues in the amino acid sequon NxT/S by oligosaccharyltransferases (OST). Artificial glycan “holes” exist when a PNGS is under-occupied on recombinant Env-based vaccines, but not on their viral counterpart. Native-like SOSIP trimers, including clinical candidates, have these artificial holes in the glycan shield that induce strain-specific neutralizing antibodies (NAbs) or non-NAbs. To increase PNGS occupancy, eliminate artificial glycan holes, and mimic the glycosylation of native BG505 Env, we replaced all 12 NxS sequons on the BG505 SOSIP trimer with NxT, thereby increasing the affinity of the sequons for OST. All PNGS, except N133 and N160, were nearly fully occupied on the modified trimer. Occupancy of the N133 site could be increased by changing N133 to NxS, while occupancy of the N160 site could be restored by reverting the nearby N156 sequon to NxS. Hence, OST affinity can influence glycan occupancy when two PNGS are in close proximity. Increasing glycan occupancy should reduce off-target immune responses to artificial glycan holes on vaccine antigens.Competing Interest StatementR. W. S. and J. P. M. are listed on patents concerning stabilized Env trimers.View Full Text
- assay: proteomics
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- research focus: cell type annotation
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
A. Torrents de la Pena, K. Rantalainen, … A. B. Ward·bioRxiv·Dec 20, 2018
- Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
J. M. Binley, E. Crooks, … L. Verkoczy·bioRxiv·Jul 20, 2021
- Impact of Glycan Depletion, Glycan Debranching and Increased Glycan Charge on HIV-1 Neutralization Sensitivity and Immunogenicity
A. D'Addabbo, T. Tong, … J. M. Binley·GlycobiologyPeer-reviewed·Aug 8, 2024
- Impact of glycan positioning on HIV-1 Env glycan shield density, function, and antibody recognition
Q. Wei, A. A. Harget, … J. Novak·bioRxiv·Mar 31, 2020
- Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation
Tuğba Atabey, Ronald Derking, … Rogier W. Sanders·Journal of VirologyPeer-reviewed·Mar 4, 2026
- HIV Envelope Trimer-Elicited Autologous Neutralizing Antibodies Bind a Region Overlapping the N332 Glycan Supersite
B. Nogal, L. E. McCoy, … A. B. Ward·bioRxiv·Nov 5, 2019